| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SPECIAL SECTION ON SYSTEMS BIOLOGY OF THE MITOCHONDRION
Divisions of 1Cardiology, 2Clinical Pharmacology, and 3Pharmacology, Department of Medicine, Case Western Reserve University and Medical Service, 4Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio; Departments of 5Anesthesiology and 6Physiology, 7Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee; 8Zablocki Veterans Affairs Medical Center, Milwaukee; and 9Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin
Submitted 16 May 2006 ; accepted in final form 7 September 2006
 |
ABSTRACT |
|---|
cardiolipin; cytochrome c; complex I; cytochrome oxidase
|
MITOCHONDRIA AS TARGETS OF DAMAGE DURING ISCHEMIA |
|---|
Cardiac mitochondria exist in two functionally distinct populations, subsarcolemmal mitochondria (SSM) that reside beneath the plasma membrane and interfibrillar mitochondria (IFM) located between the myofibrils (87, 107). SSM have a decreased capacity for calcium accumulation compared with IFM (108). Calcium loading in SSM led to the release of cytochrome c, whereas a similar extent of calcium loading in IFM did not result in cytochrome c release, even when the capacity of IFM to retain calcium was exceeded (108). Thus SSM are more susceptible to calcium overload-mediated cytochrome c release and mitochondrial damage compared with IFM (108). Progression of ischemic damage is more rapid in SSM than in IFM (45, 69, 90, 126, 140).
Complex I activity decreases during ischemia due to a decrease in the NADH dehydrogenase component (104, 120), likely due to the loss of the flavin mononucleotide coenzyme (120). Damage to the NADH dehydrogenase component of complex I can increase electron leak and the production of ROS (139). Complex I activity is also modulated by posttranslational modifications, including S-nitrosylation (22) and phosphorylation (31). Ischemia damages complex III by functional inactivation of the iron-sulfur protein (ISP) subunit (83). The 22 kDa ISP contains a 2 Fe-2 S redox-active iron-sulfur cluster. Ischemic damage to the iron-sulfur protein decreases the intensity of the electron paramagnetic resonance signal of the iron-sulfur cluster without the loss of the ISP peptide, suggesting that ischemia disrupts the cluster without degradation of the ISP subunit (83). Cytochrome oxidase, composed of 13 peptide subunits, requires the integrity of catalytic subunits (13) and of regulatory and structural subunits (8), as well as an intact inner mitochondrial membrane environment enriched in the phospholipid cardiolipin for optimal activity (119, 144). Ischemia does not lead to the functional inactivation of a subunit peptide (90). Decreased respiration through cytochrome oxidase occurs due to a selective decrease in cardiolipin content (89).
|
MITOCHONDRIA AS SOURCES OF CARDIAC INJURY DURING ISCHEMIA |
|---|
Mitochondria are a primary source for ROS production during ischemia (15, 39, 142). Superoxide production during simulated ischemia in cardiac myocytes is decreased by blockade of electron transfer into complex III (15, 142). In contrast, antimycin A blockade distal within complex III or inhibition of cytochrome oxidase increased ROS generation (15). These observations are in line with complex III as the dominant site for extra mitochondrial release of ROS (30, 59). Complex III is emerging as the major site for the production of ROS that are detected within the cardiomyocyte during ischemia.
Ischemia leads to release of cytochrome c from mitochondria. Cytochrome c content decreases in SSM at 30 min of ischemia, concomitant with cardiolipin loss (89, 90). Cardiolipin interacts with cytochrome c via nonionic (121, 122, 128) and electrostatic (106) mechanisms that localize cytochrome c at the inner membrane (106). Cardiolipin depletion delocalizes cytochrome c from the inner membrane (106, 125), the first step in cytochrome c release from mitochondria (106). A subsequent increase in permeability of the mitochondrial outer membrane then allows the loss of delocalized cytochrome c (106). Outer membrane permeability increases due to disruption of the outer membrane lipid bilayer, as a result of the activation of cytosolic and perhaps mitochondrial phospholipases (50), or the insertion of proapoptotic peptides into the mitochondrial outer membrane (73).
Cytochrome c release into cytosol occurs during ischemia in isolated rat and rabbit hearts (18, 20, 21, 89, 90). Release of cytochrome c during ischemia activates downstream caspase 3 leading to an increase in the number of cardiomyocytes displaying apoptotic markers (21) that becomes increasingly evident during reperfusion (21, 25, 53, 63). In the isolated perfused rabbit heart, the decrease in mitochondrial cytochrome c content occurs during ischemia, without additional decreases during reperfusion (81). Thus injury to mitochondria during ischemia is sufficient to release cytochrome c for activation of apoptotic pathways.
|
BLOCKADE OF ELECTRON TRANSPORT PROTECTS MITOCHONDRIA AND DECREASES ROS PRODUCTION DURING ISCHEMIA |
|---|
To address this proposed scheme during in situ ischemia in the intact heart, the ETC was inhibited with rotenone, an irreversible inhibitor of complex I. The contents of cardiolipin, cytochrome c, and the rate of oxidation through cytochrome oxidase were measured after 45 min of global ischemia in the isolated rabbit heart (80). In untreated controls, ischemia decreased the contents of cardiolipin and cytochrome c, and decreased respiration through cytochrome oxidase as described above. In the presence of rotenone-mediated blockade of electron transport, cardiolipin content was preserved in SSM even after 45 min of ischemia (80) (Fig. 1). Rotenone treatment favored the retention of cytochrome c by SSM (80) (Fig. 1). ADP-stimulated respiration through cytochrome oxidase in SSM was higher in rotenone-treated hearts (Fig. 1). Thus, blockade of the proximal ETC with rotenone, a high-affinity and irreversible inhibitor of complex I, markedly attenuated ischemic damage to cardiolipin, cytochrome c, and cytochrome oxidase, even following a relatively prolonged period of 45 min. On the basis of the critical role of cardiolipin in retaining cytochrome c within the mitochondria, it is not surprising that preservation of cardiolipin content during ischemia by rotenone treatment led to preserved cytochrome c content. Thus ischemic damage to mitochondria is mediated by the mitochondria themselves (80). Limitation of electron flow during ischemia is a new concept to limit mitochondrial damage during ischemia. Although the irreversible inhibitor rotenone was useful to test experimentally this concept, a reversible inhibitor of electron transport was required to carry the concept forward into reperfusion. In this way, the relationship between preservation of the ETC during ischemia and the reduction of myocardial injury after ischemia and reperfusion could be tested.
|
5 mM, amobarbital also inhibits succinate respiration and complex V (24). Inhibition of respiration through complex I by amobarbital is rapidly reversible (127). Amobarbital treatment of the isolated rat heart immediately before ischemia protects oxidative phosphorylation and preserves cytochrome c content in SSM and IFM during ischemia (26). This protection is concentration dependent with 2–2.5 mM providing the optimal range (26). These concentrations are consistent with those previously found to selectively inhibit complex I (61). Amobarbital treatment also preserves oxidative phosphorylation through cytochrome oxidase, previously observed with rotenone treatment. Respiration with glutamate, a complex I substrate, is also preserved (26) (Fig. 2). Thus, amobarbital must have washed out of the mitochondria during the isolation process, confirming the rapidly reversible nature of inhibition. Amobarbital avidly binds to albumin (24), and the use of isolation buffers containing bovine serum albumin during mitochondrial isolation (46, 107) favors the redistribution of amobarbital out of the mitochondria. In contrast, when rotenone was administered to the heart, glutamate respiration in isolated mitochondria was blocked (80). These findings indicate that amobarbital treatment immediately before ischemia leads to a reversible inhibition of respiration, in line with previous findings in isolated mitochondria (127) and in the isolated heart (4, 110).
|
Studies at the level of the intact heart provide additional support for the specificity of amobarbital treatment and provide insights into mechanisms of protection (2, 3). Isolated buffer-perfused guinea pig hearts were treated with either 2.5 mM amobarbital or vehicle for 1 min immediately before 30 min of ischemia, followed by 60 min of reperfusion. Mitochondrial NADH, FAD, calcium, and intracellular ROS were measured by fluorescence spectrophotometry with a fiber optic probe placed at the left ventricular free wall. Tissue autofluorescence was used to measure NADH and FAD (5–7, 115, 116, 118, 129). Mitochondrial Ca2+ concentration was measured in indo 1-AM-loaded hearts after quenching cytosolic Ca2+ with MnCl2 (116, 117, 129). ROS, primarily superoxide, was monitored in dihydroethidium (DHE) loaded hearts (23, 71, 116, 129, 146) by measuring the fluorescence of a DHE intermediate that results primarily from the reaction with superoxide (
ex, 540 nm; em, 590 nm) (146). NADH increased in both groups during early ischemia; during late ischemia, NADH declined in the vehicle group but remained elevated in the amobarbital group, consistent with in situ inhibition of complex I (Fig. 3). During late ischemia, DHE fluorescence was higher in the vehicle group than in the amobarbital group, supporting a decrease in the previously observed ROS generation during ischemia in this model (71) by blockade of electron transport with amobarbital (2, 3). Mitochondrial Ca2+ loading during ischemia was attenuated in the amobarbital-treated hearts compared with vehicle controls. Thus blockade of electron transport during ischemia preserves respiratory function in isolated mitochondria (26) accompanied by decreased production of ROS and reduced Ca2+ accumulation as evident in the intact heart (2, 3). Protection of mitochondria by blockade of electron transport at the rotenone site of complex I localizes the site of ROS production distal to complex I, most likely at complex III.
|
|
IMPROVED MITOCHONDRIAL FUNCTION DURING ISCHEMIA PRESERVES MITOCHONDRIAL FUNCTION AND DECREASES CARDIAC INJURY ON REPERFUSION |
|---|
|
The role of ischemic mitochondrial damage in myocardial injury was then addressed. Reperfusion of myocardium with reduced ischemic damage to the ETC led to improved contractile recovery, decreased marker enzyme release, and decreased infarct size following reperfusion in the isolated perfused rat heart (28) (Fig. 4). Treatment of isolated guinea pig hearts with amobarbital just before 30 min of ischemia resulted in a 87 ± 5% higher left ventricular developed pressure at 60 min of reperfusion and a 33 ± 7% smaller infarct size compared with the vehicle control group (2). Thus reperfusion of the heart in the setting of preserved mitochondrial function improved contractile recovery and decreased infarct size. The reduction of ischemic damage to cardiac mitochondria preserves mitochondrial function during reperfusion and decreases myocardial injury.
The preservation of mitochondrial function during ischemia and reperfusion by blockade of electron transport attenuates cardiac injury during reperfusion by at least two potential mechanisms. First, the capacity of cardiac mitochondria to release H2O2 during reperfusion is substantially attenuated when oxidative phosphorylation is preserved by amobarbital treatment (27) (Fig. 4). Protection of the ETC chain during ischemia by amobarbital markedly decreased net H2O2 production with both complex I and complex II substrates in isolated SSM and IFM compared with those from vehicle-treated control hearts (27). The decrease in H2O2 production with succinate as substrate in the presence of rotenone to block reverse electron flow indicates that protection of mitochondria decreases ROS production most likely from complex III. Thus preservation of respiratory function decreases mitochondrial production and release of ROS during reperfusion.
Second, blockade of electron transport during ischemia enhanced the retention of cytochrome c by cardiac mitochondria following reperfusion. Amobarbital treatment decreased state 4 respiratory rates after ischemia and reperfusion, an indicator of decreased damage to the mitochondrial inner membrane (28), protection that favors the retention of cytochrome c (89, 106). Normally the outer mitochondrial membrane is impermeable to cytochrome c (18, 145). Delocalized cytochrome c is released from mitochondria when outer-membrane permeability increases (106, 145). Blockade of electron transport during ischemia preserved outer-membrane integrity measured after reperfusion (28), unlike the increased outer-membrane permeability present in mitochondria from vehicle-treated hearts. Preserved outer-membrane integrity also favors the retention of cytochrome c by mitochondria. The mechanism leading to preserved outer-membrane integrity achieved by the reversible blockade of electron transport during ischemia is the subject of ongoing work.
The cardiac protection observed when the heart is reperfused in the setting of preserved mitochondrial function provides strong support for the working hypothesis that ischemic damage to mitochondria is a key mechanism of myocardial injury during reperfusion. Blockade of electron transport during ischemia has provided a mechanistic link regarding the key role of mitochondrial damage during ischemia in the genesis of cardiac injury during reperfusion.
|
MODULATION OF MITOCHONDRIAL FUNCTION DURING REPERFUSION PROTECTS AGAINST CONSEQUENCES OF ISCHEMIA-INDUCED MITOCHONDRIAL DAMAGE |
|---|
Pioneering studies by Ganote and colleagues (51, 52) showed that inhibition of mitochondrial respiration can decrease contraction band formation and attenuate enzyme release during reoxygenation, suggesting that resumption of mitochondrial metabolism during reoxygenation can initially lead to deleterious consequences. Reperfusion-induced declines in cardiac function and the accumulation of oxidatively damaged lipids are diminished when mitochondrial respiration was reversibly inhibited during early reperfusion using amobarbital (4), underlining the physiologic significance of mitochondrial ROS production during reperfusion to cardiac injury during reperfusion. In contrast, inhibition of cytochrome oxidase did not confer protection (4). The observed decrease in ROS production and improved myocardial protection when amobarbital was given during reperfusion strongly suggest that the site of ROS production is distal to the site of amobarbital block and proximal to cytochrome oxidase, namely complex III.
Mitochondrial permeability transition (MPT) appears to contribute to myocardial injury during ischemia (21) and especially during reperfusion (36). A component of MPT observed in situ in the heart likely occurs secondary to transient, reversible opening of the transition pore (145). Increased calcium availability during reperfusion enhances mitochondrial calcium loading (11, 55, 57). Enhanced mitochondrial oxidative damage and calcium loading predispose to the onset of MPT during reperfusion (36, 145). On the basis of their greater sensitivity to calcium-mediated damage (108), MPT during reperfusion may largely involve SSM. MPT appears to be reversible during reperfusion, with closure of the permeability transition pore enhanced by pyruvate oxidation during early reperfusion (35, 37, 58, 145). Inhibitors of MPT decrease myocardial damage during ischemia and reperfusion (36, 43, 54). Protection of mitochondrial function during ischemia by reversible inhibition of electron transport (26) led to decreased ROS production and mitochondrial calcium loading during reperfusion (2), which would be expected to decrease the probability of opening of permeability transition pore during reperfusion.
Pharmacological inhibition of mitochondrial respiration during early reperfusion by amobarbital decreases mitochondrial-driven myocardial injury during reperfusion (4). Restriction of oxidative metabolism during early reperfusion using hypoxic reperfusate also attenuates mitochondrial and cardiac damage (111, 124). Transient blockade of mitochondrial oxidative metabolism by the repetitive, brief reinstitution of intermittent stop flow ischemia, postconditioning, decreases cardiac injury (9, 147). Postconditioning decreases the generation of ROS from mitochondria (62, 124, 130). Mitochondrial calcium overload and the probability of MPT are also attenuated (9, 17, 62, 130). Thus a variety of approaches can be used to modulate the aberrant oxidative metabolism of ischemically damaged mitochondria to interrupt the link between ischemic damage to mitochondria and mitochondrial-driven cardiac injury during reperfusion.
|
IPC MODULATES MITOCHONDRIAL FUNCTION BEFORE INDEX ISCHEMIA |
|---|
(70) and PKG (34, 60). These signal transduction networks converge on mitochondria and modulate respiration (34, 136). Modulation of mitochondrial oxidative metabolism before a prolonged ischemic insult is a likely mechanism of cardioprotection. Isolation of cardiac mitochondria following the IPC stimulus, before the index ischemia, decreased mitochondrial oxidative phosphorylation in one study (38), but not another (72). As a consequence of the observation of the robust mitochondrial and myocardial protection observed after blocking electron transport during ischemia, we suggested that the IPC stimulus would decrease complex I activity and attenuate state 3 respiration through complex I as a potential mechanism of cardioprotection. IPC did not decrease state 3 respiration nor complex I activity in SSM or IFM (132). IPC increased state 4 respiration and decreased the respiratory control rate (RCR) in IFM, indicating decreased coupling of respiration, in line with the primary observations of other investigators as discussed below. Thus, protection of IPC does not occur via the relative blockade of electron transport at complex I at the onset of the sustained index ischemia. The potential of complex I to sustain post-translational modification via phosphorylation (123), nitrosylation (19, 22), or glutathionylation (32), with the potential to modulate complex I activity and respiration with complex I substrates was not observed, even when mitochondria were isolated in the presence of phosphatase inhibitors to preserve phosphorylation status (132). Thus, the cardioprotection achieved with pharmacological blockade of electron transport does not overlap with the mechanisms of IPC. The attenuation of electron transport during ischemia represents an alternative approach to cardioprotection when the triggers or effectors of IPC are impaired.
A high mitochondrial membrane potential favors ROS generation. Uncoupling of mitochondrial respiration decreases membrane potential and consequent electron leak, thereby reducing ROS production from the ETC (99). Thus, mild uncoupling of mitochondrial respiration may lead to cardiac protection. Opening of mitochondrial ATP-sensitive K+ (KATP) channel (34, 44) either by IPC or by pharmacological treatment decreases cardiac ischemia and reperfusion injury (56). The mitochondrial KATP channel is located in the inner membrane, and opening of mitochondrial KATP channels may lead to mild uncoupling (34, 74, 103). However, experimental results remain inconsistent regarding the uncoupling effect of mitochondrial KATP channel opening (105). IPC does, however, decrease ROS during simulated ischemia in cardiac myocytes (141) and during the index global ischemia in the isolated heart (71), most likely as a consequence of the uncoupling of respiration. IPC leads to the uncoupling of respiration observed in isolated mitochondria (103). Interestingly, overexpression of uncoupling protein 2, located in the mitochondrial inner membrane, protects cardiac myocytes against ischemia and reperfusion injury by reducing ROS generation and decreasing mitochondrial Ca2+ overload (135). Dinitrophenol, a chemical uncoupler of respiration protects isolated heart against ischemia and reperfusion injury when given immediately before ischemia (66, 98). Uncoupling of respiration allows the dissipation of membrane potential and circumvents the accumulation of reducing equivalents at cytochrome b of complex III (41, 42) and perhaps the iron-sulfur centers of complex I (76). The presence of reducing equivalents at these redox centers favors "electron leak" to form ROS from complex III (41, 42) and complex I (76), respectively. Preventing accumulation of reducing equivalents at complexes I and III may be especially important to decrease cytotoxic ROS production during the period of ischemia when low amounts of residual oxygen (68) are still present.
|
POSSIBLE CARDIOPROTECTION BY MILD PROTON LEAK |
|---|
|
INCREASED INJURY IN THE AGED HEART DURING ISCHEMIA AND REPERFUSION: REVERSAL BY RESTORATION OF MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION BEFORE ISCHEMIA |
|---|
In the aged heart, ischemic damage to mitochondria is superimposed upon aging-induced defects in mitochondrial oxidative metabolism (83, 84, 86, 100). We evaluated whether an intervention with the potential to improve mitochondrial function in the aged heart before ischemia could decrease myocardial injury during subsequent ischemia and reperfusion. Aging decreases oxidative function only in IFM, whereas SSM are unaffected (46). Treatment with acetylcarnitine was reported (109) to restore aging-induced decreases in cytochrome oxidase activity in the heart. We applied acetylcarnitine treatment to test whether aging-induced decreases in mitochondrial respiration could be improved.
Treatment of aged rats with acetylcarnitine increased the maximal rate of oxidative phosphorylation in IFM to rates observed in the adult heart (85). Respiration in acetylcarnitine-treated aged hearts remained well coupled (85). Adult and aged hearts next underwent 25 min of ischemia, followed by 30 min of reperfusion. In the aged heart, acetylcarnitine improved functional recovery, which was similar to the recovery of treated or untreated adult hearts (85). Acetylcarnitine markedly reduced the release of lactate dehydrogenase in the aged heart, indicating less myocyte necrosis. When the aged heart sustained ischemia and reperfusion following restoration of mitochondrial function, there was less myocardial damage and improved contractile recovery. In contrast, acetylcarnitine treatment had no effect upon the extent of myocardial damage or contractile recovery in the adult heart. These observations provide strong support for the contribution of aging-related defects in mitochondrial metabolism to the enhanced cardiac damage observed following ischemia and reperfusion.
Acetylcarnitine could improve aging defects in electron transport by two mechanisms. First, acetylcarnitine was proposed to increase the content of cardiolipin (109), required for optimal activity of cytochrome oxidase (119, 144). However, aging did not decrease the content of cardiolipin in the aged Fischer 344 rat heart (101). Second, treatment with acetylcarnitine increases transcription of mitochondrial DNA in the aged heart leading to increased mitochondrial protein synthesis and an increased content of mitochondrial-encoded electron transport subunits (49). Regardless of the mechanism, the option to modulate mitochondrial oxidative metabolism by treating age-related, rather than ischemia-induced, damage in a preemptive fashion represents a novel cardioprotective strategy for the aged heart.
Our working model for increased injury in the aged heart is that addition of ischemia-induced defects upon preexisting aging defects would enhance mitochondrial-derived myocyte injury in the aged heart (86). Consistent with previous observations in the adult heart, mitochondrial damage occurred mainly during ischemia, rather than during reperfusion, in the aged heart (86). The contribution of the ETC to damage during ischemia in the aged heart was tested by using rotenone to block electron flow. Rotenone treatment of aged hearts immediately before the onset of ischemia attenuated ischemic damage to IFM (86). Thus, as in the adult heart, the ETC contributes to mitochondrial damage during ischemia in the aged heart. Amobarbital treatment immediately before ischemia (26) protects oxidative phosphorylation in the aged heart following reperfusion (C. Tanaka-Esposito, Q. Chen, and E. J. Lesnefsky, unpublished observations). Thus reversible blockade of electron transport can attenuate the ischemic component of mitochondrial damage in the aged as well as in the adult rat heart.
These studies demonstrate the potential to independently modulate both the age-related and ischemia-induced components of mitochondrial oxidative metabolism that contribute to injury to the aged heart by directly targeting the mitochondrion. Relief of aging-related defects in oxidative metabolism can decrease ischemic myocardial injury in the aged heart (85). In addition, blockade of electron transport attenuates the ischemic mitochondrial damage in the adult and senescent hearts. Future work will uncover the potential interactive benefit of these complimentary approaches to reduce synergistically injury to the aged heart during ischemia and reperfusion.
In summary, the blockade of electron transport or the partial uncoupling of respiration lessens cardiac injury during ischemia and during early reperfusion. Although the concept that disrupting effective oxidative metabolism to protect the heart initially appears counterintuitive, both of these interventions decrease the accumulation of reducing equivalents at key centers in the electron transport chain, namely complex I and complex III, under conditions that favor ROS generation. The protection achieved is mediated via the decreased production and release of ROS from mitochondria, less mitochondrial calcium overload, and the improved retention of cytochrome c by mitochondria. Future work is required to clarify whether decreased calcium overload and cytochrome c release occur as consequences of decreased oxidative injury. It increasingly appears that the cardioprotective paradigms of IPC and postconditioning at least in part modulate mitochondrial oxidative metabolism as effector mechanisms. The initially paradoxical approach to limit mitochondrial oxidative phosphorylation in pathological settings in fact provides a new cardioprotective paradigm. The restriction of mitochondrial oxidative metabolism by therapeutic intervention or via the activation of signaling cascades is a key mechanism of cardiac protection during ischemia and reperfusion. This conceptual approach should continue to foster the evolution of mitochondrial-based treatments to limit cardiac injury during ischemia as well as during reperfusion.
|
GRANTS |
|---|
|
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
2. Aldakkak M, Heisner JS, Stowe DF, Chen Q, Lesnefsky EJ, Heinen A, Rhodes SS, Camara AK. Inhibition of mitochondrial complex I during ischemia protects hearts, preserves mitochondrial NADH, and reduces mitochondrial Ca2+ overload and ROS production (Abstract). Circulation 112: II-286, 2005.
3. Aldakkak M, Stowe DF, Heisner JS, Stowe DF, Lesnefsky EJ, Chen Q, Heinen A, Rhodes SS, Camara AK. Amobarbital, high K+ and lidocaine protect hearts against ischemia reperfusion injury by differential changes in mitochondrial bioenergetics (Abstract). FASEB J 20: A319, 2006.
4. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, Chiariello M. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268: 18532–18541, 1993.
5. An J, Camara AK, Rhodes SS, Riess ML, Stowe DF. Warm ischemic preconditioning improves mitochondrial redox balance during and after mild hypothermic ischemia in guinea pig isolated hearts. Am J Physiol Heart Circ Physiol 288: H2620–H2627, 2005.
6. An J, Camara AK, Riess ML, Rhodes SS, Varadarajan SG, Stowe DF. Improved mitochondrial bioenergetics by anesthetic preconditioning during and after 2 hours of 27°C ischemia in isolated hearts. J Cardiovasc Pharmacol 46: 280–287, 2005.[CrossRef][ISI][Medline]
7. An JZ, Rhodes SS, Jiang MT, Bosnjak ZJ, Stowe DF. Anesthetic preconditioning enhances calcium handling and metabolic and mechanical function elicited by Na+/Ca2+ exchange inhibition in isolated hearts. Anesthesiology. 105: 541–549, 2006.[CrossRef][ISI][Medline]
8. Anthony G, Reimann A, Kadenbach B. Tissue-specific regulation of bovine heart cytochrome-c oxidase activity by ADP via interaction with subunit VIa. Proc Natl Acad Sci USA 90: 1652–1656, 1993.
9. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194–197, 2005.
10. Asimakis GK, Conti VR. Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory function. J Mol Cell Cardiol 16: 439–447, 1984.[CrossRef][ISI][Medline]
11. Ataka K, Chen D, Levitsky S, Jimenez E, Feinberg H. Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation 86: 371–376, 1992.
12. Azhar G, Gao W, Liu L, Wei JY. Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol 34: 699–714, 1999.[CrossRef][ISI][Medline]
13. Babcock GT, Varotsis C. Discrete steps in dioxygen activation–the cytochrome oxidase/O2 reaction. J Bioenerg Biomembr 25: 71–80, 1993.[CrossRef][ISI][Medline]
14. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61: 461–470, 2004.
15. Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240–H2246, 1999.
16. Bolli R, McCay PB. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning". Free Radic Res Commun 9: 169–180, 1990.[ISI][Medline]
17. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69: 178–185, 2006.
18. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS Lett 541: 1–5, 2003.[CrossRef][ISI][Medline]
19. Borutaite V, Budriunaite A, Brown GC. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim Biophys Acta 1459: 405–412, 2000.[Medline]
20. Borutaite V, Budriunaite A, Morkuniene R, Brown GC. Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. Biochim Biophys Acta 1537: 101–109, 2001.[Medline]
21. Borutaite V, Jekabsone A, Morkuniene R, Brown GC. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol 35: 357–366, 2003.[CrossRef][ISI][Medline]
22. Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394: 627–634, 2006.[CrossRef][ISI][Medline]
23. Camara AKS, Riess ML, Kevin LG, Novallja E, Stowe DF. Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart. Am J Physiol Heart Circ Physiol 286: H1289–H1299, 2004.
24. Chance B, Williams GR, Hollunger G. Inhibition of electron and energy transfer in mitochondria. I. Effects of Amytal, thiopental, rotenone, progesterone, and methylene glycol. J Biol Chem 238: 418–431, 1963.
25. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276: 30724–30728, 2001.
26. Chen Q, Hoppel CL, Lesnefsky EJ. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther 316: 200–207, 2006.
27. Chen Q, Hoppel CL, Lesnefsky EJ. Reperfusion with preserved mitochondrial function decreases mitochondrial hydrogen peroxide production and infarct size (Abstract). FASEB J 20: A318, 2006.
28. Chen Q, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects myocardium by preserving mitochondrial function (Abstract). Circ Res 97: e937-e938, 2005.[CrossRef]
29. Chen Q, Lesnefsky EJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 40: 976–982, 2006.[CrossRef][ISI][Medline]
30. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278: 36027–36031, 2003.
31. Chen R, Fearnley IM, Peak-Chew SY, Walker JE. The phosphorylation of subunits of complex I from bovine heart mitochondria. J Biol Chem 279: 26036–26045, 2004.
32. Chen YR, Chen CL, Zhang L, Green-Church KB, Zweier JL. Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation. J Biol Chem 280: 37339–37348, 2005.
33. Cortese JD, Voglino AL, Hackenbrock CR. The ionic strength of the intermembrane space of intact mitochondria is not affected by the pH or volume of the intermembrane space. Biochim Biophys Acta 1100: 189–197, 1992.[CrossRef][Medline]
34. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97: 329–336, 2005.
35. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529: 11–21, 2000.
36. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233–249, 1999.
37. Crompton M, Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol 88: 513–523, 1993.[CrossRef][ISI][Medline]
38. Da Silva MM, Sartori A, Belisle E, Kowaltowski AJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport. Am J Physiol Heart Circ Physiol 285: H154–H162, 2003.
39. Davies MJ. Direct detection of radical production in the ischaemic and reperfused myocardium: current status. Free Radic Res Commun 7: 275–284, 1989.[ISI][Medline]
40. Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta 1364: 222–235, 1998.[Medline]
41. Demin OV, Kholodenko BN, Skulachev VP. A model of O2·– generation in the complex III of the electron transport chain. Mol Cell Biochem 184: 21–33, 1998.[CrossRef][ISI][Medline]
42. Demin OV, Westerhoff HV, Kholodenko BN. Mathematical modeling of superoxide generation with the bc1 complex of mitochondria. Biochemistry (Mosc) 63: 634–649, 1998.[Medline]
43. Di Lisa F, Bernardi P. Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res 66: 222–232, 2005.
44. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Thambo JB, Tariosse L, Garlid KD. Mechanisms by which opening the mitochondrial ATP- sensitive K+ channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284–H295, 2002.
45. Duan J, Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts follow
TOP
ABSTRACT
MITOCHONDRIA AS TARGETS OF...
